Global Veterinary Imaging Market revenues to reach US$ 3.37 Bn by 2030: Future Market Insights
During the projected era, a growing focus on preserving animal welfare and well-being is expected to generate major opportunities for...
Year: 2021
EV Biologics Designs Process for Scalable Exosome Biopharmaceutical Manufacturing
NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1...
Rapid Nutrition Launches New Investor Relations Website
NEW YORK, NY / ACCESSWIRE / February 22, 2021 / As announced earlier this month, Rapid Nutrition PLC (OTCQB:RPNRF)(SW:RAP), a...
Enzolytics Updates Permitting Progress in Europe on Its Planned Clinical Trials of Its Patented ITV-1 Anti-HIV and Other Developments
COLLEGE STATION, TX / ACCESSWIRE / February 22, 2021 / Enzolytics, Inc. (OTC Markets "ENZC" or the "Company") today announced...
PPJ Healthcare Enterprises, Inc. Updates its Shareholders on the Upcoming Projects
TAMPA, FL / ACCESSWIRE / February 22, 2021 / PPJ Healthcare Enterprises Inc. (OTC PINK:PPJE) announced today that it is...
Champions Oncology Announces Addition to Board of Directors
HACKENSACK, NJ / ACCESSWIRE / February 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR) a leading global oncology technology solutions provider transforming...
Bacteriophage Probiotics to generate over 9 out 10 Sales Attributed to Surging Antibiotic Resistance: Fact.MR
Excessive antibiotics consumption is leading to an upsurge in numerous gastrointestinal disorders, prompting increased bacteriophage products uptake ROCKVILLE, MD /...
MediXall Group Announces New Transfer Agent
FORT LAUDERDALE, FL / ACCESSWIRE / February 22, 2021 / MediXall Group, Inc. (OTCQB:MDXL), a healthcare technology company, announced today...
UPDATE – Megola Recaps Recent Q3
Acquisitions, Debts Paid, Canceled Shares, Exit Shell Status LAS VEGAS, NV / ACCESSWIRE / February 22, 2021 / Megola Inc. (OTC PINK:MGON)...
Celcuity Announces Proposed Public Offering of Common Stock
MINNEAPOLIS, MN / ACCESSWIRE / February 22, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical stage biotechnology company translating discoveries of...
Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF
Novamind included as fast entry addition to the North American Psychedelics Index, the underlying index of the Horizons Psychedelic Stock...
Adverum Appoints Esteemed Healthcare Executive Reed V. Tuckson, M.D., to Board of Directors
REDWOOD CITY, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...
Jushi Holdings Inc. Announces Participation at Upcoming Conferences in February and March 2021
Company’s Executive Leadership Selected to Participate at SXSW Online 2021BOCA RATON, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings...
Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") announced today that the U.S. Food and...
Resonant to Present at Arete Tech Conference on March 3rd
Resonant Management and Advisory Board to Speak on RF Filter Industry PanelAUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Resonant...
PureK Holdings Corp. Announces Three-for-One Forward Stock Split
VANCOUVER, British Columbia, Feb. 22, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company") (TSX Venture: PKAN) announces that the...
PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine
Brazilian-based Blanver brings depth of expertise in development and commercialization of innovative pharmaceuticals across Latin AmericaFLORHAM PARK, N.J., Feb. 22,...
Myovant Sciences to Present at Upcoming Investor Conferences
BASEL, Switzerland, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women...
Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
WATERTOWN, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics...
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on March 1, 2021
CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
